Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/205751
Title: | Cytotoxic peripheral T-cell lymphomas and EBV-positive T/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP/SH lymphoma workshop |
Author: | Climent, Fina Nicolae, Alina Leval, Laurence de Dirnhofer, Stefan Leoncini, Lorenzo Ondrejka, Sarah L. Soma, Lorinda Wotherspoon, Andrew Zamo, Alberto Quintanilla Martinez, Leticia Ng, Siok Bian |
Keywords: | Micro RNAs Espanya MicroRNAs Spain |
Issue Date: | 30-Aug-2023 |
Publisher: | Springer Science and Business Media LLC |
Abstract: | Cytotoxic peripheral T-cell lymphomas and EBV-positive T/NK-cell lymphoproliferative diseases were discussed at the 2022 European Association for Haematopathology/Society for Hematopathology lymphoma workshop held in Florence, Italy. This session focused on (i) primary nodal EBV-positive T and NK-cell lymphomas (primary nodal-EBV-TNKL), (ii) extranodal EBV-positive T/NK lymphoproliferative diseases (LPD) in children and adults, (iii) cytotoxic peripheral T-cell lymphomas, NOS (cPTCL-NOS), EBV-negative, and (iv) miscellaneous cases. Primary nodal-EBV-TNKL is a newly recognized entity which is rare, aggressive, and associated with underlying immune deficiency/immune dysregulation. All cases presented with lymphadenopathy but some demonstrated involvement of tonsil/Waldeyer's ring and extranodal sites. The majority of tumors are of T-cell lineage, and the most frequent mutations involve the epigenetic modifier genes, such as TET2 and DNMT3A, and JAK-STAT genes. A spectrum of EBV-positive T/NK LPD involving extranodal sites were discussed and highlight the diagnostic challenge with primary nodal-EBV-TNKL when these extranodal EBV-positive T/NK LPD cases demonstrate predominant nodal disease either at presentation or during disease progression from chronic active EBV disease. The majority of cPTCL-NOS demonstrated the TBX21 phenotype. Some cases had a background of immunosuppression or immune dysregulation. Interestingly, an unexpected association of cPTCL-NOS, EBV-positive and negative, with TFH lymphomas/LPDs was observed in the workshop cases. Similar to a published literature, the genetic landscape of cPTCL-NOS from the workshop showed frequent mutations in epigenetic modifiers, including TET2 and DNMT3A, suggesting a role of clonal hematopoiesis in the disease pathogenesis. |
Note: | Reproducció del document publicat a: https://doi.org/10.1007/s00428-023-03616-4 |
It is part of: | Virchows Archiv, 2023, vol. 483, num. 3, p. 333-348 |
URI: | http://hdl.handle.net/2445/205751 |
Related resource: | https://doi.org/10.1007/s00428-023-03616-4 |
ISSN: | 1432-2307 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
s00428-023-03616-4.pdf | 3.17 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License